IN-VIVO DEMONSTRATION OF REDUCED BENZODIAZEPINE RECEPTOR BINDING IN HUMAN EPILEPTIC FOCI
- 1 October 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 332 (8616), 863-866
- https://doi.org/10.1016/s0140-6736(88)92468-3
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PETJournal of Cerebral Blood Flow & Metabolism, 1988
- Magnetic resonance imaging in temporal lobe epilepsy: Pathological correlationsAnnals of Neurology, 1987
- Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PETScience, 1986
- Kinetics and displacements of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomographyEuropean Journal of Pharmacology, 1985
- Imaging of [11C]-labelled RO 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomographyJournal of Psychiatric Research, 1985
- The GABA postsynaptic membrane receptor-ionophore complexMolecular and Cellular Biochemistry, 1981
- Head Fixation Device for Reproducible Position Alignment in Transmission CT and Positron Emission TomographyJournal of Computer Assisted Tomography, 1981
- Inhibitory, GABAergic Nerve Terminals Decrease at Sites of Focal EpilepsyScience, 1979
- Benzodiazepine Receptor: Demonstration in the Central Nervous SystemScience, 1977
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949